Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cussotto

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Radiology|January 1, 1997
Quiz case of the month. Right ureteral-peritoneal fistula with haematoperitoneumF Sardanelli, C Ottonello, M Calabrese, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Intravesical idarubicin: a dose-finding studyF Boccardo, D Cannata, M Cussotto, et al.
Anticancer Research|January 1, 1996
Combination therapy with subcutaneous interleukin-2 and interferon-alpha in advanced renal cancer patients with poor prognostic factorsL Canobbio, A Curotto, D Cannata, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 1, 1994
DNA flow cytometry as a surrogate end-point in patients with superficial bladder cancer treated with 4-HPRA Decensi, A Curotto, S Bruno, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Radiology|January 1, 1997
Quiz case of the month. Right ureteral-peritoneal fistula with haematoperitoneumF Sardanelli, C Ottonello, M Calabrese, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Intravesical idarubicin: a dose-finding studyF Boccardo, D Cannata, M Cussotto, et al.
Anticancer Research|January 1, 1996
Combination therapy with subcutaneous interleukin-2 and interferon-alpha in advanced renal cancer patients with poor prognostic factorsL Canobbio, A Curotto, D Cannata, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 1, 1994
DNA flow cytometry as a surrogate end-point in patients with superficial bladder cancer treated with 4-HPRA Decensi, A Curotto, S Bruno, et al.
Pageof 1